Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07746674

Central Line-Associated Bloodstream Infection QI Project

This study evaluates a daily electronic health record (EHR) alert designed to reduce unnecessary central venous catheter (CVC) use among hospitalized adults. The alert identifies patients with an active CVC and no documented indication, prompting the first-contact provider to document line necessity. The study compares alert and a secure chat intervention to usual care, with the goal of reducing unnecessary line days and related CLABSI risk.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Central Line-associated Bloodstream Infection (CLABSI)

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

NYU Langone Health

New York, 10016, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Not hospice patient class
  • Active central line for at least 24 hours

Exclusion criteria

  • No active central line
  • Central line present for less than 24 hours

Treatment and study plan

Primary outcomes

  1. Total number of central line days without a documented indication

    Time frame: Up to Month 3

Secondary outcomes

  1. Number of femoral central lines in place for more than 2 days

    Time frame: Up to Month 3

  2. Number of non-tunneled hemodialysis catheters without an active hemodialysis or continuous renal replacement therapy order

    Time frame: Up to Month 3

Study contacts

Contact information is provided by the study sponsor or research team.

Holly Krelle

CONTACT

[email protected]

347-200-1108

Sarah Tsuruo

CONTACT

[email protected]

914-815-4079

Sponsors and collaborators

Lead sponsor

NYU Langone Health

Other

Registry information

Official study title

Central Line-Associated Bloodstream Infection (CLABSI) Quality Improvement Project

Acronym: CLABSI

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
Aug 5, 2026
Registry last updated
Aug 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.